Compare PKX & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKX | STE |
|---|---|---|
| Founded | 1968 | 1985 |
| Country | South Korea | United States |
| Employees | N/A | 3700 |
| Industry | Steel/Iron Ore | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 21.6B |
| IPO Year | 1998 | 2018 |
| Metric | PKX | STE |
|---|---|---|
| Price | $53.24 | $229.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $275.20 |
| AVG Volume (30 Days) | 338.9K | ★ 648.1K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.36% | 1.19% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | N/A | ★ $5,935,900,000.00 |
| Revenue This Year | $5.61 | $9.88 |
| Revenue Next Year | $3.56 | $6.32 |
| P/E Ratio | $42.95 | ★ $29.05 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $44.99 | $195.14 |
| 52 Week High | $92.40 | $269.44 |
| Indicator | PKX | STE |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 61.18 |
| Support Level | $50.73 | $217.07 |
| Resistance Level | $55.23 | $267.89 |
| Average True Range (ATR) | 1.30 | 5.18 |
| MACD | 0.74 | 1.91 |
| Stochastic Oscillator | 78.20 | 76.20 |
POSCO Holdings Inc is a holding company operating through its subsidiaries. Its business is divided into segments, with the Steel segment generating the majority of revenue from the manufacture and sale of steel products. The Infrastructure segment includes trading, construction, and logistics and system integration activities. The Rechargeable Battery Materials segment focuses on EV battery materials such as lithium, nickel, and cathode and anode materials. The Others segment includes the controlling company and investment business. Geographically, the Group generates majority of its revenue from Asia (excluding China and Japan).
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.